These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9412668)
41. Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy. Purdy JA; Harms WB; Michalski J; Cox JD Front Radiat Ther Oncol; 1996; 29():255-63. PubMed ID: 8742907 [No Abstract] [Full Text] [Related]
42. A geometric model for evaluating the effects of inter-fraction rectal motion during prostate radiotherapy. Pavel-Mititean LM; Rowbottom CG; Hector CL; Partridge M; Bortfeld T; Schlegel W Phys Med Biol; 2004 Jun; 49(12):2613-29. PubMed ID: 15272677 [TBL] [Abstract][Full Text] [Related]
43. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria. Gordon JJ; Sayah N; Weiss E; Siebers JV Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863 [TBL] [Abstract][Full Text] [Related]
44. Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy. Lee R; Chan EK; Kosztyla R; Liu M; Moiseenko V Phys Med Biol; 2012 Dec; 57(24):8297-307. PubMed ID: 23190583 [TBL] [Abstract][Full Text] [Related]
45. Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer? Purdy JA; Michalski JM Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):867-70. PubMed ID: 11704308 [No Abstract] [Full Text] [Related]
46. New technologies for the radiotherapy of prostate cancer. A discussion of clinical treatment programs. Meyer JL; Leibel S; Roach M; Vijayakumar S Front Radiat Ther Oncol; 2007; 40():315-337. PubMed ID: 17641517 [No Abstract] [Full Text] [Related]
47. Importance of accurate dose calculations outside segment edges in intensity modulated radiotherapy treatment planning. Schwarz M; Bos LJ; Mijnheer BJ; Lebesque JV; Damen EM Radiother Oncol; 2003 Dec; 69(3):305-14. PubMed ID: 14644490 [TBL] [Abstract][Full Text] [Related]
48. Rectal dose reduction with IMRT for prostate radiotherapy. Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012 [TBL] [Abstract][Full Text] [Related]
49. Radiobiological effect based treatment plan optimization with the linear quadratic model. Schell S; Wilkens JJ; Oelfke U Z Med Phys; 2010; 20(3):188-96. PubMed ID: 20832006 [TBL] [Abstract][Full Text] [Related]
50. Impact of different leaf velocities and dose rates on the number of monitor units and the dose-volume-histograms using intensity modulated radiotherapy with sliding-window technique. Vorwerk H; Wagner D; Hess CF Radiat Oncol; 2008 Sep; 3():31. PubMed ID: 18811954 [TBL] [Abstract][Full Text] [Related]
51. [Dose-volume histograms for optimization of radiotherapy planning based on the example of esophageal carcinoma]. Roth J; Hünig R; Hügli C Strahlenther Onkol; 1995 Mar; 171(3):149-53. PubMed ID: 7709331 [TBL] [Abstract][Full Text] [Related]
52. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate. Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384 [TBL] [Abstract][Full Text] [Related]
53. Dose due to scattered radiation in external radiotherapy: a prostate cancer case history. Cigna AA; Nassisi D; Masenga D; Raffo R; Rotta P Radiat Prot Dosimetry; 2004; 108(1):27-32. PubMed ID: 14974602 [TBL] [Abstract][Full Text] [Related]
54. The influence of the bowel and bladder preparation protocol for radiotherapy of prostate cancer using kilo-voltage cone beam CT: Our experience. Heng SP; Low SH; Sivamany K Indian J Cancer; 2015; 52(4):639-44. PubMed ID: 26960504 [TBL] [Abstract][Full Text] [Related]
55. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187 [TBL] [Abstract][Full Text] [Related]
56. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978 [TBL] [Abstract][Full Text] [Related]
57. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639 [TBL] [Abstract][Full Text] [Related]
59. Colour visualization as an aid to the comparison of treatment plans for prostatic carcinoma. Hahn P; Shalev S; Therrien P Acta Oncol; 1987; 26(4):313-5. PubMed ID: 3689585 [TBL] [Abstract][Full Text] [Related]
60. A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results. Song JS; Albert M; D'Amico AV; Cormack RA Med Phys; 2005 Feb; 32(2):437-47. PubMed ID: 15789590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]